• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Iranian Journal of Pharmaceutical Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 18 (2019)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 17 (2018)
Volume Volume 16 (2017)
Volume Volume 15 (2016)
Volume Volume 14 (2015)
Volume Volume 13 (2014)
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
kabiri, M., Kamalinejad, M., Bioos, S., Shariat, M., Sohrabvand, F. (2019). Comparative Study of the Effects of Chamomile (Matricaria Chamomilla L.) and Cabergoline on Idiopathic Hyperprolactinemia: A Pilot Randomized Controlled Trial. Iranian Journal of Pharmaceutical Research, 18(3), 1612-1621. doi: 10.22037/ijpr.2019.1100758
Marya kabiri; Mohammad Kamalinejad; Soodabeh Bioos; Mamak Shariat; Farnaz Sohrabvand. "Comparative Study of the Effects of Chamomile (Matricaria Chamomilla L.) and Cabergoline on Idiopathic Hyperprolactinemia: A Pilot Randomized Controlled Trial". Iranian Journal of Pharmaceutical Research, 18, 3, 2019, 1612-1621. doi: 10.22037/ijpr.2019.1100758
kabiri, M., Kamalinejad, M., Bioos, S., Shariat, M., Sohrabvand, F. (2019). 'Comparative Study of the Effects of Chamomile (Matricaria Chamomilla L.) and Cabergoline on Idiopathic Hyperprolactinemia: A Pilot Randomized Controlled Trial', Iranian Journal of Pharmaceutical Research, 18(3), pp. 1612-1621. doi: 10.22037/ijpr.2019.1100758
kabiri, M., Kamalinejad, M., Bioos, S., Shariat, M., Sohrabvand, F. Comparative Study of the Effects of Chamomile (Matricaria Chamomilla L.) and Cabergoline on Idiopathic Hyperprolactinemia: A Pilot Randomized Controlled Trial. Iranian Journal of Pharmaceutical Research, 2019; 18(3): 1612-1621. doi: 10.22037/ijpr.2019.1100758

Comparative Study of the Effects of Chamomile (Matricaria Chamomilla L.) and Cabergoline on Idiopathic Hyperprolactinemia: A Pilot Randomized Controlled Trial

Article 42, Volume 18, Issue 3, Summer 2019, Page 1612-1621  XML PDF (600.12 K)
Document Type: Research article
DOI: 10.22037/ijpr.2019.1100758
Authors
Marya kabiri1; Mohammad Kamalinejad2; Soodabeh Bioos1; Mamak Shariat3; Farnaz Sohrabvand email 4
1School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran.
2School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3Institute of Family Health, Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran.
4Vali-e-Asr Hospital, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Abstract
Chamomile is a fascinating plant quoted in several traditional medicine texts, which has
broad-spectrum pharmacological activity and medicinal uses. The aim of this study was to
assess the efficacy of chamomile syrup in reducing serum prolactin in women with idiopathic
hyperprolactinemia. The study was a randomized, controlled clinical trial that was conducted
on 56 women with idiopathic hyperprolactinemia for a study period of four weeks. Patients
were randomly enrolled in two parallel arms and were treated by chamomile syrup at a dose
of 5 mL twice daily or cabergoline tablet orally at a dose of 0.25 mg twice weekly. Serum
prolactin levels were measured at baseline and the end of the 4-week study period. Any report
of adverse events was also recorded. Results revealed that within the cabergoline group the
reduction in the mean prolactin level was significantly greater than that of the chamomile
group (
p <0.0001). It was also found that decline in the mean prolactin level was statistically
significant within the chamomile group (
p <0.0001). Chamomile syrup seems to be effective
on serum prolactin reduction in women with idiopathic hyperprolactinemia. However, studies
with a larger sample size and for a longer follow-up period are recommended.
Keywords
Hyperprolactinemia; Matricaria chamomilla; Cabergoline; Prolactin; Complementary medicine; Chamomile
Main Subjects
Pharmacognosy
Statistics
Article View: 170
PDF Download: 247
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Statistics

Journal Management System. Designed by sinaweb.